ICER’s Growing Influence on Drug Value
The Institute for Clinical and Economic Review (ICER) has grown to become a leading voice on drug pricing in the US. As the emphasis on value in the US health care system and concern over high drug prices continues to grow, more stakeholders are likely to look to ICER for guidance on whether a drug […]